Form 4: Tenon Medical Director's Routine Stock Transactions

Tenon Medical Director Robert K. Weigle converted restricted stock units into common stock and subsequently sold shares to cover tax liabilities.

Summary

• Robert K. Weigle, a Director of Tenon Medical, Inc. (TNON), reported changes in his beneficial ownership.
• On January 1, 2026, 10,732 restricted stock units (RSUs), which were granted on October 13, 2025, converted into 10,732 shares of common stock.
• Following this conversion, Mr. Weigle's direct beneficial ownership of common stock increased to 10,965 shares.
• On January 5, 2026, Mr. Weigle disposed of 3,413 shares of common stock at a price of $0.9301 per share.
• These shares were sold to satisfy tax liabilities associated with the vesting of the RSUs.
• After these transactions, Mr. Weigle directly beneficially owns 7,552 shares of Tenon Medical, Inc. common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction involving RSU vesting and a subsequent tax-related sale. While the sale reduces insider ownership, it is a common practice and does not necessarily indicate a negative outlook on the company. The overall sentiment is neutral.

Positives

• The vesting of 10,732 restricted stock units represents a compensation event for the director, indicating the fulfillment of equity-based incentives.

Negatives

• Director Robert K. Weigle sold 3,413 shares of common stock, which reduced his direct beneficial ownership in the company.

Future Outlook

Not applicable; this Form 4 filing reports past insider transactions and does not contain forward-looking statements or guidance.

Industry Context

This filing details a routine insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Related Party Transactions

• The transactions involve Robert K. Weigle, a Director of Tenon Medical, Inc., which constitutes a related party transaction in the context of insider reporting.

Stakeholder Impact

• Shareholders: A minor reduction in direct insider ownership by a director, which is a common occurrence following equity compensation vesting.

Key Dates

Keywords

Tenon Medical, TNON, Form 4, insider trading, beneficial ownership, restricted stock units, RSU vesting, stock sale, director, Robert K. Weigle, common stock